Home/All Molecules/Inositol Myo D-Chiro

Inositol Myo D-Chiro Range

Comprehensive Inositol Myo D-Chiro portfolio for Franchise & Manufacturing.

Category
inositolmyo-d-chiro
Total Formulations
0
Available Forms

Expand Your Business with Our Multiple Divisions


Browse Inositol Myo D-Chiro portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Inositol Myo D-Chiro batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Inositol Myo D-Chiro PCD Pharma Franchise

Inositol Myo D-Chiro PCD Pharma Franchise Company

Cafoli Lifecare offers a specialised Inositol (Myo-Inositol with D-Chiro-Inositol) PCD pharma franchise range for the fast-growing women’s health and metabolic segment. Manufactured under WHO-GMP certified standards, this range gives franchise partners a science-backed nutraceutical line for gynaecology and endocrinology prescribers.

What is Inositol Myo D-Chiro?

Myo-Inositol and D-Chiro-Inositol are naturally occurring inositol isomers that act as second messengers in the insulin signalling pathway. Supplemented together, typically in a physiological 40:1 ratio, they help improve insulin sensitivity and restore ovulatory function, which is why they are widely used to support polycystic ovary syndrome (PCOS) and insulin resistance. Learn more on PubChem.

Therapeutic Applications of Inositol Myo D-Chiro

The Inositol Myo D-Chiro range is used for the management of polycystic ovary syndrome (PCOS), insulin resistance, metabolic syndrome and as supportive therapy in female infertility and ovulation support. It is prescribed largely by gynaecologists, reproductive endocrinologists and physicians managing metabolic health.

Why Inositol Myo D-Chiro is a High-Potential Molecule for Distributors

PCOS affects a large and rising share of reproductive-age women in India, and inositol-based therapy has become a mainstream, well-tolerated first choice alongside or ahead of metformin. This creates durable, repeat-purchase demand in the high-margin women’s-wellness category, making Inositol an attractive differentiator for distributors expanding into gynaecology and nutraceuticals.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers exclusive district-wise monopoly rights, WHO-GMP certified and DCGI-approved formulations, attractive promotional inputs and marketing support, and the reliability of a network trusted by 1000+ franchise partners across India.

References

  1. PubChem – myo-Inositol Compound Summary, U.S. National Library of Medicine
  2. PubMed – Inositol in PCOS: clinical literature

Aceclofenac in Modern Clinical Practice

Our formulations of Inositol Myo D-Chiro find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Inositol Myo D-Chiro in PCD Franchise

Start Your Inositol Myo D-Chiro Franchise with Cafoli Lifecare. Partner with us for quality Inositol Myo D-Chiro formulations backed by monopoly rights and complete promotional support. Call 9518447302 or email info@cafoli.in to book your territory today.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers Myo-Inositol and D-Chiro-Inositol based formulations, usually in the standard 40:1 ratio with co-factors, for PCD franchise and third-party manufacturing partners.

Yes. Cafoli Lifecare provides exclusive district-wise monopoly rights so your territory is protected from internal competition.

It is prescribed mainly by gynaecologists, reproductive endocrinologists and physicians for PCOS, insulin resistance and fertility support.

PCOS is highly prevalent and chronic, and inositol therapy is repeat-purchase and well-tolerated, giving steady demand in the growing nutraceutical segment.

A valid Drug License and GST registration are required. On submission, Cafoli Lifecare issues your monopoly agreement and promotional inputs.